RxDoctor Payments Data

Niti Amin, PA

Physician Assistant · Zephyrhills, FLNPI 1114356573

Payments from drug & device makers

$5,184in general payments, 2019–2025

Across 192 payments — averaging $27.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$556
  • Sun Pharmaceutical Industries Inc.$429
  • Novartis$398
  • Sanofi$353
  • Dermavant Sciences, Inc.$292
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,99596%
  • Education$1894%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,184 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$28,950
Medicare patients
107
Services billed
577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast13$62,446
Ketoconazole380$5,802
Clobetasol Propionate125$5,550
Fluorouracil58$4,584
Ammonium Lactate137$3,388
Calcipotriene11$3,310
Pimecrolimus21$3,152
Tacrolimus20$2,992
Clindamycin Phosphate67$2,175
Metronidazole37$2,020
Triamcinolone Acetonide168$1,498
Gentamicin Sulfate25$1,321
Mupirocin182$1,093
Mometasone Furoate46$866
Hydrocortisone186$819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$281$62,44613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Zephyrhills

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →